| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90112-50ul | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| HRP | NBP2-79659-5Plates | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| HRP | NBP2-79343-5Plates | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| HRP | NBP2-79401-5Plates | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| HRP | NBP2-79440-5Plates | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-06096-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50161-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-50421-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26676-50ul | |||
![ELISA: Human CD46 ELISA Kit (Colorimetric) [NBP3-39834] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39834_human-cd46-elisa-kit-colorimetric-2110202415403159.png "ELISA: Human CD46 ELISA Kit (Colorimetric) [NBP3-39834] - Standard Curve Reference")
![Flow Cytometry: CD59 Antibody (029) [NBP2-90112] - Analysis of Human CD59 expression on human whole blood lymphocytes. Cells were stained with purified anti-Human CD59, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes.](http://images.novusbio.com/fullsize/CD59-Antibody-029-Flow-Cytometry-NBP2-90112-img0001.jpg "Flow Cytometry: CD59 Antibody (029) [NBP2-90112] - Analysis of Human CD59 expression on human whole blood lymphocytes. Cells were stained with purified anti-Human CD59, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable lymphocytes.")
![Sandwich ELISA: Fc gamma RIII (CD16) Antibody Pair [HRP] [NBP2-79659] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.](http://images.novusbio.com/fullsize/Fc-gamma-RIII-CD16-Antibody-Pair-HRP-Sandwich-ELISA-NBP2-79659-img0001.jpg "Sandwich ELISA: Fc gamma RIII (CD16) Antibody Pair [HRP] [NBP2-79659] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.")
![ELISA: Human CD46 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39835] - Standard Curve Reference](http://images.novusbio.com/fullsize/nbp3-39835_human-cd46-ready-to-use-elisa-kit-colorimetric-2110202415282660.png "ELISA: Human CD46 - Ready-To-Use ELISA Kit (Colorimetric) [NBP3-39835] - Standard Curve Reference")
![Sandwich ELISA: CEACAM5/CD66e Antibody Pair [HRP] [NBP2-79343] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.](http://images.novusbio.com/fullsize/CEACAM5-CD66e-Antibody-Pair-[HRP]-Sandwich-ELISA-NBP2-79343-img0001.jpg "Sandwich ELISA: CEACAM5/CD66e Antibody Pair [HRP] [NBP2-79343] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.")
![Sandwich ELISA: CD59 Antibody Pair [HRP] [NBP2-79401]](http://images.novusbio.com/fullsize/CD59-Antibody-Pair-[HRP]-Sandwich-ELISA-NBP2-79401-img0001.jpg "Sandwich ELISA: CD59 Antibody Pair [HRP] [NBP2-79401]")
![Sandwich ELISA: CD55/DAF Antibody Pair [HRP] [NBP2-79440] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.](http://images.novusbio.com/fullsize/CD55-DAF-Antibody-Pair-[HRP]-Sandwich-ELISA-NBP2-79440-img0001.jpg "Sandwich ELISA: CD55/DAF Antibody Pair [HRP] [NBP2-79440] - This standard curve is only for demonstration purposes. A standard curve should be generated for each assay.")
![Flow Cytometry: CD72 Antibody (108) [NBP3-06096] - Flow cytometric analysis of Mouse CD59a expression on BABLc bone marrow erythroid cells. Cells were stained with purified anti-Mouse CD59a, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of erythroid cells.](http://images.novusbio.com/fullsize/CD72-Antibody-108-Flow-Cytometry-NBP3-06096-img0001.jpg "Flow Cytometry: CD72 Antibody (108) [NBP3-06096] - Flow cytometric analysis of Mouse CD59a expression on BABLc bone marrow erythroid cells. Cells were stained with purified anti-Mouse CD59a, then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of erythroid cells.")
![Flow Cytometry: CD59 Antibody (28D4) [NBP3-26676] - Overlay Peak curve showing Hela cells stained with CD59 Antibody (28D4) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26676_rabbit-cd59-mab-28d4-282202414183671.jpg "Flow Cytometry: CD59 Antibody (28D4) [NBP3-26676] - Overlay Peak curve showing Hela cells stained with CD59 Antibody (28D4) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")